Trial Information

Summary: Moderate to Severe Plaque Psoriasis

This study of an investigational systemic medication for plaque psoriasis will last approximately 52 weeks, requiring approximately 17 visits to the Longmont Clinic. The Principal Investigator is Scott Clark, M.D.

Criteria to participate

  • At least 18 years of age
  • Diagnosed with psoriasis for at least 6 months
  • Have moderate to severe plaque psoriasis
  • Generally heallthy

The study provides

  • All study related or required exams
  • Study medication
  • Compensation for time and travel

Contact:

Stacy
Longmont Medical Research Network
Located in:
Longmont, CO 80501
Telephone: 303-776-8717
Email:

Profile Page: Longmont Medical Research Network, Longmont, CO

  

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: February 25, 2008 at 3:24:19 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA